Clearpoint Neuro Stock Alpha and Beta Analysis

CLPT Stock  USD 12.80  0.24  1.91%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Clearpoint Neuro. It also helps investors analyze the systematic and unsystematic risks associated with investing in Clearpoint Neuro over a specified time horizon. Remember, high Clearpoint Neuro's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Clearpoint Neuro's market risk premium analysis include:
Beta
1.96
Alpha
0.41
Risk
5.18
Sharpe Ratio
(0.06)
Expected Return
(0.29)
Please note that although Clearpoint Neuro alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Clearpoint Neuro did 0.41  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Clearpoint Neuro stock's relative risk over its benchmark. Clearpoint Neuro has a beta of 1.96  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Clearpoint Neuro will likely underperform. At this time, Clearpoint Neuro's Book Value Per Share is comparatively stable compared to the past year. Tangible Book Value Per Share is likely to gain to 0.97 in 2025, whereas Enterprise Value Over EBITDA is likely to drop (21.22) in 2025.

Enterprise Value

419.11 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Clearpoint Neuro Backtesting, Clearpoint Neuro Valuation, Clearpoint Neuro Correlation, Clearpoint Neuro Hype Analysis, Clearpoint Neuro Volatility, Clearpoint Neuro History and analyze Clearpoint Neuro Performance.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Clearpoint Neuro Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Clearpoint Neuro market risk premium is the additional return an investor will receive from holding Clearpoint Neuro long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Clearpoint Neuro. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Clearpoint Neuro's performance over market.
α0.41   β1.96

Clearpoint Neuro expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Clearpoint Neuro's Buy-and-hold return. Our buy-and-hold chart shows how Clearpoint Neuro performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Clearpoint Neuro Market Price Analysis

Market price analysis indicators help investors to evaluate how Clearpoint Neuro stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clearpoint Neuro shares will generate the highest return on investment. By understating and applying Clearpoint Neuro stock market price indicators, traders can identify Clearpoint Neuro position entry and exit signals to maximize returns.

Clearpoint Neuro Return and Market Media

The median price of Clearpoint Neuro for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 15.89 with a coefficient of variation of 11.31. The daily time series for the period is distributed with a sample standard deviation of 1.81, arithmetic mean of 15.97, and mean deviation of 1.52. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Dalessandro Danilo of 1949 shares of Clearpoint Neuro at 4.53 subject to Rule 16b-3
12/31/2024
2
Heres What Could Help ClearPoint Neuro Maintain Its Recent Price Strength
01/02/2025
3
Acquisition by Mazin Sabra of 65252 shares of Clearpoint Neuro subject to Rule 16b-3
01/10/2025
4
Acquisition by Mazin Sabra of 6913 shares of Clearpoint Neuro subject to Rule 16b-3
01/17/2025
5
ClearPoint Neuro Trading 8.5 percent Higher - Still a Buy - MarketBeat
02/07/2025
6
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
02/14/2025
7
Disposition of 908 shares by Stigall L. Jeremy of Clearpoint Neuro at 16.72 subject to Rule 16b-3
02/21/2025
8
ClearPoint Neuro Inc Q4 2024 Everything You Need To Know Ahead Of Earnings
02/25/2025
9
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
02/26/2025
10
ClearPoint Neuro Inc Q4 2024 Earnings Call Highlights Strong Revenue Growth and ...
02/27/2025
11
Acquisition by Joseph Burnett of 132841 shares of Clearpoint Neuro subject to Rule 16b-3
03/03/2025
12
ClearPoint Neuro Projected to Post Quarterly Earnings on Tuesday
03/04/2025
13
Disposition of 47407 shares by Joseph Burnett of Clearpoint Neuro subject to Rule 16b-3
03/06/2025
14
Disposition of 4146 shares by Dalessandro Danilo of Clearpoint Neuro subject to Rule 16b-3
03/11/2025

About Clearpoint Neuro Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Clearpoint or other stocks. Alpha measures the amount that position in Clearpoint Neuro has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 2025 (projected)
Payables Turnover25.8126.319.166.06
Days Of Inventory On Hand483.7279.23204.19394.35

Clearpoint Neuro Upcoming Company Events

As portrayed in its financial statements, the presentation of Clearpoint Neuro's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clearpoint Neuro's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Clearpoint Neuro's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Clearpoint Neuro. Please utilize our Beneish M Score to check the likelihood of Clearpoint Neuro's management manipulating its earnings.
6th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Clearpoint Neuro

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.